Alembic Pharmaceuticals Limited (APLLTD) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.076x

Based on the latest financial reports, Alembic Pharmaceuticals Limited (APLLTD) has a cash flow conversion efficiency ratio of 0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.03 Billion ≈ $43.57 Million USD) by net assets (Rs53.16 Billion ≈ $574.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Alembic Pharmaceuticals Limited worth for the company's overall valuation and market capitalisation.

Alembic Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Alembic Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Alembic Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alembic Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Explore cash flow quality index of Alembic Pharmaceuticals Limited to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Primaris Retail R.E. Invest. Tr. Units TO:PMZ-UN	0.024x
Dime Community Bancshares, Inc. NYSE:DCOM	0.037x
Tianjin Port Co Ltd SHG:600717	0.036x
Margun Enerji Uretim Sanayi ve Ticaret AS IS:MAGEN	-0.037x
Chambal Fertilizers & Chemicals Limited NSE:CHAMBLFERT	0.035x
Zydus Wellness Limited NSE:ZYDUSWELL	0.070x
Sonos Inc NASDAQ:SONO	-0.170x
SJW Group Common Stock NYSE:SJW	0.031x

Annual Cash Flow Conversion Efficiency for Alembic Pharmaceuticals Limited (2011–2025)

The table below shows the annual cash flow conversion efficiency of Alembic Pharmaceuticals Limited from 2011 to 2025. View APLLTD live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs51.90 Billion ≈ $561.23 Million	Rs879.70 Million ≈ $9.51 Million	0.017x	-89.83%
2024-03-31	Rs48.18 Billion ≈ $521.07 Million	Rs8.03 Billion ≈ $86.86 Million	0.167x	+0.64%
2023-03-31	Rs43.70 Billion ≈ $472.65 Million	Rs7.24 Billion ≈ $78.29 Million	0.166x	+57.07%
2022-03-31	Rs52.38 Billion ≈ $566.42 Million	Rs5.52 Billion ≈ $59.73 Million	0.105x	-63.48%
2021-03-31	Rs50.67 Billion ≈ $547.97 Million	Rs14.63 Billion ≈ $158.26 Million	0.289x	+105.16%
2020-03-31	Rs31.90 Billion ≈ $345.04 Million	Rs4.49 Billion ≈ $48.57 Million	0.141x	-52.88%
2019-03-31	Rs27.18 Billion ≈ $293.94 Million	Rs8.12 Billion ≈ $87.81 Million	0.299x	+112.32%
2018-03-31	Rs22.20 Billion ≈ $240.13 Million	Rs3.12 Billion ≈ $33.79 Million	0.141x	-7.37%
2017-03-31	Rs19.01 Billion ≈ $205.61 Million	Rs2.89 Billion ≈ $31.23 Million	0.152x	-73.87%
2016-03-31	Rs16.01 Billion ≈ $173.09 Million	Rs9.30 Billion ≈ $100.62 Million	0.581x	+199.39%
2015-03-31	Rs8.85 Billion ≈ $95.67 Million	Rs1.72 Billion ≈ $18.58 Million	0.194x	-44.47%
2014-03-31	Rs6.76 Billion ≈ $73.06 Million	Rs2.36 Billion ≈ $25.55 Million	0.350x	-33.59%
2013-03-31	Rs5.03 Billion ≈ $54.39 Million	Rs2.65 Billion ≈ $28.64 Million	0.527x	+47.78%
2012-03-31	Rs3.95 Billion ≈ $42.72 Million	Rs1.41 Billion ≈ $15.22 Million	0.356x	+9.39%
2011-03-31	Rs2.95 Billion ≈ $31.93 Million	Rs961.81 Million ≈ $10.40 Million	0.326x	--

About Alembic Pharmaceuticals Limited

NSE:APLLTD India Drug Manufacturers - Specialty & Generic

Market Cap

$1.80 Billion

Rs166.24 Billion INR

Market Cap Rank

#6593 Global

#304 in India

Share Price

Rs845.75

Change (1 day)

+2.39%

52-Week Range

Rs646.55 - Rs960.70

All Time High

Rs1247.70